326 related articles for article (PubMed ID: 27566546)
1. Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors.
Weston C; Winfield I; Harris M; Hodgson R; Shah A; Dowell SJ; Mobarec JC; Woodlock DA; Reynolds CA; Poyner DR; Watkins HA; Ladds G
J Biol Chem; 2016 Oct; 291(42):21925-21944. PubMed ID: 27566546
[TBL] [Abstract][Full Text] [Related]
2. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
5. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
[TBL] [Abstract][Full Text] [Related]
6. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.
Roehrkasse AM; Warner ML; Booe JM; Pioszak AA
J Biol Chem; 2020 Jul; 295(28):9736-9751. PubMed ID: 32487746
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
9. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
10. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
13. Variable CGRP family peptide signaling durations and the structural determinants thereof.
Babin KM; Gostynska SE; Karim JA; Pioszak AA
Biochem Pharmacol; 2024 Jun; 224():116235. PubMed ID: 38670438
[TBL] [Abstract][Full Text] [Related]
14. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.
Takhshid MA; Poyner DR; Chabot JG; Fournier A; Ma W; Zheng WH; Owji AA; Quirion R
Br J Pharmacol; 2006 Jun; 148(4):459-68. PubMed ID: 16702994
[TBL] [Abstract][Full Text] [Related]
15. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
[TBL] [Abstract][Full Text] [Related]
16. The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.
Woolley MJ; Watkins HA; Taddese B; Karakullukcu ZG; Barwell J; Smith KJ; Hay DL; Poyner DR; Reynolds CA; Conner AC
J R Soc Interface; 2013 Nov; 10(88):20130589. PubMed ID: 24047872
[TBL] [Abstract][Full Text] [Related]
17. CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells.
Clark AJ; Mullooly N; Safitri D; Harris M; de Vries T; MaassenVanDenBrink A; Poyner DR; Gianni D; Wigglesworth M; Ladds G
Commun Biol; 2021 Jun; 4(1):776. PubMed ID: 34163006
[TBL] [Abstract][Full Text] [Related]
18. Ectodomain structures of the CGRP and AM receptors.
Kusano S; Yokoyama S
Curr Protein Pept Sci; 2013 Aug; 14(5):375-85. PubMed ID: 23745701
[TBL] [Abstract][Full Text] [Related]
19. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
Hay DL; Walker CS; Poyner DR
Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]